Implementation of personalized medicine services in community pharmacies: Perceptions of independent community pharmacists

Assessing Feasibility of Delivering Pharmacogenetic Testing in a Community Pharmacy Setting

“…Thus, this would be the first study to comprehen sively assess the delivery of PGx testing in actual com munity pharmacy setting, providing a more realistic assessment of patient response and pharmacy barri ers/facilitators to offer PGx testing as a routine ser vice. Pharmacists have expressed interest in delivering PGx testing [55], but educational and feasibility con cerns must be addressed. Several factors may impact the delivery of PGx testing in a pharmacy setting, including pharmacy workflow demands, provider responsive ness to pharmacist requests to approve the test and other health system factors.…”

Proposal for a Pharmacogenetics Certificate Program for Pharmacists

“…Given the reported limited knowledge of pharmacists about pharmacogenetics [18], this proposed format for a certification may require more intense initial self-study. A report of an ACPE program demonstrated some improvement in pharmacists' knowledge of PGx, but still a relatively low knowledge level following the completion of the program (precourse score: 46%; postcourse score: 53%) [19].…”

“…Although they have acknowledged their limited knowledge of this field [6,18] and need for further training to increase their confidence in providing PGx testing [7,19,20], there are few data that specify the content of PGx education for pharmacists. Romagnoli et al [21] categorized 36 informational needs into four broad categories based on pharmacist interviews: background; specific medication and drug-gene details; patient-specific clinical information; and PGx guidance-related information.…”

Ethical Perspectives on Translational Pharmacogenetic Research Involving Children

“…They may also have expectations that these results will be used for current or future medical decisions. However, while patients and the public expect a high level of information and effective communication from their health care professionals in the area of pharmacogenetics and adverse drug reactions [30][31][32], a gap exists between patients' expectations and health care professionals' knowledge in this field [31,[33][34][35].…”